top of page
Medscape.jpeg

New “Peters on Diabetes” Videos

Holman.jpg
PetersOnDiabetes_0522-1.tiff
Wright.jpg
New “Peters on Diabetes” Videos​

Dr. Peters has a new collection of her news and opinion videos from her Peters on Diabetes series that include comments from the European Association for the Study of Diabetes (EASD) meeting in Stockholm in September. Mark also provided coverage on other topics from that meeting for Medscape as well as reporting from the July ATDC Conference in Keystone. CO. 

 

These videos are announced in our Twitter feed and Facebook page and will also be updated here as they become available. A free one-time registration on Medscape is required to view the videos.

 

 

 

 

 

 

 

 

 

 

 


 

 

'First Step' Toward Delaying Progression of Type 1 Diabetes 

Dr Anne Peters discusses the approval of teplizumab and its potential impact in delaying the onset of stage 3 diabetes for patients age 8 years or older who currently have stage 2 type 1 diabetes.

Medscape Diabetes & Endocrinology, November 22, 2022

 

Pemafibrate Didn't Improve CV Outcomes in Patients With T2D  

Dr Anne Peters discusses the PROMINENT trial, which found that pemafibrate lowered triglycerides in patients with diabetes and hypertriglyceridemia but didn't improve cardiovascular outcomes.

Medscape Diabetes & Endocrinology, November 21, 2022

 

Updates on Glycemic Control in Type 2 Diabetes From EASD 2022

Updates on glycemic control for type 2 diabetes from EASD 2022 focus on ADA/EASD guidelines on hyperglycemia and results of a 44-year prospective study of diabetes, as reported by Dr AnnePeters.

Medscape Diabetes & Endocrinology, Oct 14, 2022

 

Advances in Insulin Therapy for Type 2 Diabetes From EASD 2022

From EASD 2022, Dr Anne Peters reports on the latest updates on insulin therapy for T2D, including the data from the ONWARDS 2 trial and a subanalysis of the SoliMix trial.

Medscape Diabetes & Endocrinology, Oct 12, 2022

 

'Patients Need a Champion' for Their Diabetes Care 

How do you advocate for your patients? How do you make sure their care is equitable? Anne L. Peters, MD, discusses the importance of advocacy.

Medscape Diabetes & Endocrinology, October 03, 2022

FreeStyle Libre 3: 'Almost Like Wearing Nothing' 

Dr Anne Peters offers insight into her patients' reactions to the FreeStyle Libre 3 CGM, the smallest sensor available.

Medscape Diabetes & Endocrinology, September 06, 2022

Videos from the 58th European Association for the Study of Diabetes (EASD) Annual Meeting held on September 20 - 29th, 2022

 

Flash CGM Sustainably Reduces Acute Hospitalizations in T2D

Jean-Pierre Riveline, PhD, discusses results from a study demonstrating how continuous glucose monitoring may be used to fight clinical inertia.

Medscape Diabetes & Endocrinology, October 21, 2022

 

Does Spinal Cord Stimulation Improve Diabetic Neuropathy?

Rod S. Taylor, MSc, PhD, discusses a recent trial using spinal cord stimulation for painful diabetic neuropathy and its potential for long-term use in improving pain and quality of life.

Medscape Diabetes & Endocrinology, October 19, 2022

 

Is Brain Insulin Important for Whole-Body Metabolism?

How does brain insulin resistance affect metabolism? Martin Heni, MD, discusses findings from a recent study along with treatment approaches for brain insulin resistance.

Medscape Diabetes & Endocrinology, October 17, 2022

 

How Well Do Your Patients With Diabetes Cope With Change?

Does glycemic control improve in patients with better psychological resilience? Yes and no, reports Simon M. Brackley, MD, who provides an overview of new findings. 

Medscape Diabetes & Endocrinology, October 14, 2022

'Urgent Low Soon' Alert Decreases Hypoglycemia After Exercise in T1D

Sian Rilstone, BSc, MSc, discusses the benefits of the "urgent low soon" alert for continuous glucose monitoring on hypoglycemia after exercise in patients with type 1 diabetes.

Medscape Diabetes & Endocrinology, Oct 10, 2022

 

Life Expectancy Shorter in Women With Type 2 Diabetes vs Men

Why is life expectancy for women with type 2 diabetes shorter than for men with the disease? Andrew H. Heald, MD, discusses the findings from 10-year of data and possible contributors to the results.

Medscape Diabetes & Endocrinology, Oct 4, 2022

Reducing Waste, Going Green With Diabetes Technology

What are the initiatives to decrease waste from diabetes technology? Lutz Heinemann, PhD, discusses steps to move toward green diabetes.

Medscape Diabetes & Endocrinology, Sep 29, 2022

UKPDS Legacy Effects: The Importance of Treating Hyperglycemia Early

Dr Rury Holman gives an update on the latest findings from the UK Prospective Diabetes Study. What have we learned from 44 years of data on complications in type 2 diabetes?

Medscape Diabetes & Endocrinology, September 27, 2022

Videos from the Barbara Davis Center ATDC Conference in Keystone, Colorado on July 14-17th, 2022

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Earlier Is Better: Treat Patients Before Type 2 Diabetes Develops  

Ralph DeFronzo, MD, discusses treating type 2 diabetes early and using combination treatments to correct the eight pathophysiologic defects. 

Medscape Diabetes & Endocrinology, August 26, 2022

Integrated Care and New Technologies in Type 1 Diabetes 

Chantal Mathieu, MD, PhD, discusses access to care, integrated care, and new technologies in type 1 diabetes in Europe.

Medscape Diabetes & Endocrinology, August 25, 2022

Automated Insulin Delivery: The Next Generation of Research  

Greg Forlenza, MD, discusses the next generation of automated insulin delivery research.

Medscape Diabetes & Endocrinology, August 23, 2022

What's New and Upcoming in CGMs?  

Jennifer Sherr, MD, PhD, discusses advances in continuous glucose monitoring technologies, including current and anticipated FDA approvals, and what this means for patients.

Medscape Diabetes & Endocrinology, August 19, 2022

Turn to PANTHER to Understand Diabetes Technology  

Cari Berget, RN, MPH, discusses the PANTHER program, a resource for healthcare professionals looking to find practical, usable information related to diabetes technology.

Medscape Diabetes & Endocrinology, August 15, 2022

Get the Complete Picture by Using CGM for Those With Diabetes  

Eugene Wright, MD, discusses why you should be using continuous glucose monitoring in the primary care setting for your patients with diabetes.

Medscape Diabetes & Endocrinology, August 11, 2022

Closing the Gap on Diabetes Care in Minority Populations  

Andrea Gerard Gonzalez, MD, discusses the programs that the Barbara Davis Center Latino Center has implemented to provide better diabetes care to minority populations.

Medscape Diabetes & Endocrinology, August 09, 2022

A Brighter Future for Those With Type 1 Diabetes  

Aaron Kowalski, PhD, shares his personal and professional perspective on new technology for those with type 1 diabetes and his hope for the future.

Medscape Diabetes & Endocrinology, August 02, 2022

L A T E S T   N E W S

AnnePeters_2022.jpg

MESSAGE FROM THE DIRECTOR

It is often hard to appreciate the progress that has been made in the understanding and treatment of diabetes...

READ MORE...

covered-california-logo.png

HEALTH POLICY LOWERS INSULIN, COVERED CALIFORNIA COST

Seniors who use insulin can look forward to reduction in their monthly insulin cost sharing cap to $35 a month...

READ MORE...

Lobby2.jpg

CHANGES AT THE USC WESTSIDE CENTER FOR DIABETES

Our clinic has moved one floor down in the same building to provide more space for patients and staff...                      

READ MORE...

Medtronic-extended-reservoir.jpg

DIABETES TECHNOLOGY UPDATE

Since the last newsletter both the Omnipod 5 automated insulin delivery (AID) system and...

READ MORE...

T1Dstages.png

'FIRST STEP' TOWARD DELAYING PROGRESSION OF TYPE 1 DIABETES

Tzield (teplizumab), is the first disease-modifying therapy for individuals at-risk for developing T1D...

READ MORE...

Medscape.jpeg

NEW “PETERS ON DIABETES” VIDEOS

Dr. Peters has a new collection of her news and opinion videos from her Peters on Diabetes series that include...,

READ MORE...

CGM2.png

WINTER RESEARCH UPDATE

A new affordable insulin pen company is looking for feedback on a revolutionary design of what they called a Go-Pen...

READ MORE...

bottom of page